uft 100 mg/224 mg capsulas duras
merck, s.l. - tegafur, uracilo - excipientes: laurilsulfato de sodio - antimetabolitos - análogos de las pirimidinas - tegafur, combinaciones con
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasmas estomacales - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
paltegafur 100mg/224mg capsula
palmagyar s.a. - capsula - por capsula - tegafur, combinaciones